Utility of Simple and Non-Invasive Strategies Alternative to Inferior Petrosal Sinus Sampling and Peripheral CRH Stimulation in Differential Diagnosis of ACTH-Dependent Cushing Syndrome

Abstract

We aimed to evaluate the utility of simple, cost-effective, and non-invasive strategies alternative to BIPSS and peripheral CRH stimulation in differential diagnosis of ACTH-dependent CS. First, we performed ROC analysis to evaluate the performance of various tests for differential diagnosis of ACTH-dependent CS in our cohort (CD, n=76 and EAS, n=23) and derived their optimal cut-offs. Subsequently, combining various demographic (gender), clinical (hypokalemia), biochemical (plasma ACTH, HDDST, peripheral CRH stimulation) and imaging (MRI pituitary) parameters, we derived non-invasive models with 100% PPV for CD. Patients with pituitary macroadenoma (n=14) were excluded from the analysis involving non-invasive models. Relative percent ACTH (AUC: 0.933) and cortisol (AUC: 0.975) increase on peripheral CRH stimulation demonstrated excellent accuracy in discriminating CD from EAS. Best cut-offs for CD were plasma ACTH<97.3 pg/ml, HDDST≥57% cortisol suppression, CRH stimulation≥77% ACTH increase and≥11% cortisol increase. We derived six models that provided 100% PPV for CD and precluded the need for BIPPS in 35/85 (41.2%) patients with ACTH-dependent CS and no macroadenoma (in whom BIPSS would have otherwise been recommended). The first three models included basic parameters and avoided both peripheral CRH stimulation and BIPSS in 19 (22.4%) patients, while the next three models included peripheral CRH stimulation and avoided BIPSS in another 16 (18.8%) patients. Using simple and non-invasive alternative strategies, BIPSS can be avoided in 41% and peripheral CRH stimulation in 22% of patients with ACTH-dependent CS and no macroadenoma; such patients can be directly referred for a pituitary surgery.

Keywords

Cushing disease - ACTH-dependent Cushing syndrome - BIPSS - CRH stimulation - non-invasive

Publication History

Received: 13 November 2023

Accepted after revision: 28 December 2023

Accepted Manuscript online:
28 December 2023

Article published online:
16 February 2024

• References

• 1 Nieman LK. Molecular derangements and the diagnosis of ACTH-dependent Cushing's syndrome. Endocr Rev 2022; 43: 852-877
• 2 Ferrante E, Barbot M, Serban AL. et al. Indication to dynamic and invasive testing in Cushing's disease according to different neuroradiological findings. J Endocrinol Invest 2022; 45: 629-637
• 3 Nieman LK, Biller BMK, Findling JW. et al. Treatment of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015; 100: 2807-2831
• 4 Hayes AR, Grossman AB. The ectopic adrenocorticotropic hormone syndrome: rarely easy, always challenging. Endocrinol Metab Clin North Am 2018; 47: 409-425
• 5 Zampetti B, Grossrubatscher E, Dalino Ciaramella P. et al. Bilateral inferior petrosal sinus sampling. Endocr Connect 2016; 5: R12-R25
• 6 Fleseriu M, Auchus R, Bancos I. et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol 2021; 9: 847-875
• 7 Ammini AC, Tandon N, Gupta N. et al. Etiology and clinical profile of patients with Cushing's syndrome: A single center experience. Indian J Endocrinol Metab 2014; 18: 99-105
• 8 Nishioka H, Yamada S. Cushing's disease. J Clin Med 2019; 8: 1951
• 9 Swearingen B, Katznelson L, Miller K. et al. Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab 2004; 89: 3752-3763
• 10 Detomas M, Ritzel K, Nasi-Kordhishti I. et al. Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing’s syndrome: results from a retrospective multicenter study. Eur J Endocrinol 2023; 188: 448-456
• 11 Ferring-CRH GHRH. Published 2022. https:// www. ese-hormones.org/ media/ 4911/ ferring-pharmaceuticals-response- crh-ghrh-december- 2022
• 12 Ceccato F, Barbot M, Ceccato F. et al. Shortage of hCRH for the diagnosis of endogenous CS: the end of an era or the beginning of a new journey?. J Endocrinol Invest 2023; 46: 2189-2191
• 13 Attri B, Goyal A, Kalaivani M. et al. Clinical profile and treatment outcomes of patients with ectopic ACTH syndrome compared to Cushing disease: a single-center experience. Endocrine 2023; 80: 408-418
• 14 Meier CA, Biller BM. Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 1997; 26: 741-762
• 15 Frete C, Corcuff JB, Kuhn E. et al. Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 2020; 105: dgaa409
• 16 Lyu X, Zhang D, Pan H. et al. A noninvasive scoring model for the differential diagnosis of ACTH-dependent Cushing's syndrome: a retrospective analysis of 311 patients based on easy-to-use parameters. Endocrine 2022; 78: 114-122
• 17 Valizadeh M, Ahmadi AR, Ebadinejad A. et al. Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing's syndrome: a systematic review and meta-analysis. Rev Endocr Metab Disord 2022; 23: 881-892
• 18 Chen S, Chen K, Wang S. et al. The optimal cut-off of BIPSS in differential diagnosis of ACTH-dependent Cushing's syndrome: is stimulation necessary?. J Clin Endocrinol Metab 2020; 105: dgz194
• 19 Ceccato F, Barbot M, Mondin A. et al. Dynamic testing for differential diagnosis of ACTH-dependent Cushing syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab 2023; 108: e178-e188
• 20 Vassiliadi DA, Tsagarakis S. Diagnosis of endocrine disease: the role of the desmopressin test in the diagnosis and follow-up of Cushing's syndrome. Eur J Endocrinol 2018; 178: R201-R214
• 21 Terzolo M, Reimondo G, Alì A. et al. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome. Clin Endocrinol (Oxf) 2001; 54: 609-616
• 22 Aron DC, Raff H, Findling JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 1780-1785
• 23 Lila AR, Sarathi V, Jagtap VS. et al. Cushing's syndrome: Stepwise approach to diagnosis. Indian J Endocrinol Metab 2011; 15: S317-S321
• 24 Gupta R, Walia R, Ahuja C. et al. Limited invasive protocol: optimizing diagnostic modalities in corticotropin mediated Cushing syndrome. Endocr Pract 2022; 28: 767-773
• 25 Young J, Haissaguerre M, Viera-Pinto O. et al. Management of endocrine disease: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion. Eur J Endocrinol 2020; 182: R29-R58
• 26 Newell- Price J, Trainer P, Besser M. et al. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998; 19: 647-672
• 27 de Keyzer Y, Lenne F, Auzan C. et al. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 1996; 97: 1311-1318
• 28 Newell-Price J, Morris DG, Drake WM. et al. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing’s syndrome. J Clin Endocrinol Metab 2002; 87: 1640-1645
• 29 Detomas M, Ritzel K, Nasi-Kordhishti I. et al. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome. Front Endocrinol 2022; 13: 955945
• 30 Ceccato F, Tizianel I, Vedolin CK. et al. Human corticotropin-releasing hormone tests: 10 years of real-life experience in pituitary and adrenal disease. J Clin Endocrinol Metab 2020; 105: dgaa564
• 31 Wright K, van Rossum EFC, Zan E. et al. Emerging diagnostic methods and imaging modalities in cushing's syndrome. Front Endocrinol (Lausanne) 2023; 14: 1230447
• 32 Walia R, Gupta R, Bhansali A. et al. Molecular imaging targeting corticotropin-releasing hormone receptor for corticotropinoma: a changing paradigm. J Clin Endocrinol Metab 2021; 106: e1816-e1826
• 33 Detomas M, Deutschbein T, Tamburello M. et al. Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study. J Endocrinol Invest 2023;
• 34 Detomas M, Altieri B, Chifu I. et al. Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism. Eur J Endocrinol 2022; 187: 439-449